z-logo
open-access-imgOpen Access
Evaluation of the Collateral Activity Of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer
Author(s) -
Leonid K. Kurbatov,
Sergey P. Radko,
Svetlana A. Khmeleva,
О.С. Тимошенко,
Andrey V. Lisitsa
Publication year - 2022
Publication title -
biomedical chemistry: research and methods
Language(s) - English
Resource type - Journals
ISSN - 2618-7531
DOI - 10.18097/bmcrm00169
Subject(s) - ribonuclease , crispr , heterologous , rna , computational biology , recombinant dna , collateral damage , ribosomal rna , chemistry , chromatography , computer science , biology , biochemistry , criminology , sociology , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here